Literature DB >> 30306390

Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.

Florian Obermair1,2, Melanie Rammer3, Jonathan Burghofer3, Theodora Malli3, Anna Schossig4, Katharina Wimmer4, Wolfgang Kranewitter3, Beate Mayrbaeurl5, Hans-Christoph Duba6, Gerald Webersinke3.   

Abstract

Hereditary diffuse gastric cancer (HDGC) is an autosomal-dominantly inherited cancer syndrome associated with a high risk for diffuse gastric and lobular breast cancer, caused by heterozygous CDH1 germline mutations. Of note, also cleft lip/palate (CLP) has been described in few HDGC families. Here we report on an extensive pedigree presenting with HDGC, CLP and a CDH1 splice site mutation (c.687 + 1G > A) and review the literature for families with CDH1 mutations, HDGC and CLP. Transcript analysis showed that the c.687 + 1G > A mutation leads to loss of the last 42 bp of exon 5 and is consequently predicted to cause loss of 14 amino acids in the first extracellular cadherin repeat (EC) domain. Five mutation carriers developed diffuse gastric cancer and four individuals presented with CLP. Wild type CDH1 expression levels did not differ between CDH1 mutation carriers with CLP compared to those without CLP. Beside this extensive pedigree, we outline another previously unreported HDGC/CLP family with a CDH1 (c.1711 + 1G > C) germline mutation in this study. Review of the literature revealed a significant enrichment of CDH1 mutations within the EC domains in CLP/HDGC families (Fisher's exact test, p = 0.007) in comparison to CDH1 mutations associated with HDGC only. Report of further CLP/HDGC associated mutations is necessary to confirm this observation. This study highlights that CLP represents an important phenotypic feature of CDH1 germline mutation carriers and emphasizes the inclusion of CLP in the HDGC testing criteria. The underlying causes for the appearance of variable phenotypes in CDH1 mutation carriers could include genetic variation, epigenetic changes and environmental factors and should be investigated in future studies.

Entities:  

Keywords:  CDH1 protein; Hereditary; Human; Neoplastic syndromes; Orofacial cleft; Stomach neoplasms

Mesh:

Substances:

Year:  2019        PMID: 30306390     DOI: 10.1007/s10689-018-0111-5

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  25 in total

1.  Family history of cleft lip and palate in subjects diagnosed with leukemia.

Authors:  Aditi Jindal; Alexandre R Vieira
Journal:  Am J Med Genet A       Date:  2012-02-02       Impact factor: 2.802

2.  Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.

Authors:  Samantha Hansford; Pardeep Kaurah; Hector Li-Chang; Michelle Woo; Janine Senz; Hugo Pinheiro; Kasmintan A Schrader; David F Schaeffer; Karey Shumansky; George Zogopoulos; Teresa Almeida Santos; Isabel Claro; Joana Carvalho; Cydney Nielsen; Sarah Padilla; Amy Lum; Aline Talhouk; Katie Baker-Lange; Sue Richardson; Ivy Lewis; Noralane M Lindor; Erin Pennell; Andree MacMillan; Bridget Fernandez; Gisella Keller; Henry Lynch; Sohrab P Shah; Parry Guilford; Steven Gallinger; Giovanni Corso; Franco Roviello; Carlos Caldas; Carla Oliveira; Paul D P Pharoah; David G Huntsman
Journal:  JAMA Oncol       Date:  2015-04       Impact factor: 31.777

3.  Cancer risk in persons with oral cleft--a population-based study of 8,093 cases.

Authors:  Camilla Bille; Jeanette Falck Winther; Andrea Bautz; Jeffrey C Murray; Jørn Olsen; Kaare Christensen
Journal:  Am J Epidemiol       Date:  2005-06-01       Impact factor: 4.897

4.  CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling.

Authors:  Irma Kluijt; Ester J M Siemerink; Margreet G E M Ausems; Theo A M van Os; Daphne de Jong; Joana Simões-Correia; J Han van Krieken; Marjolijn J Ligtenberg; Joana Figueiredo; Els van Riel; Rolf H Sijmons; John T M Plukker; Richard van Hillegersberg; Evelien Dekker; Carla Oliveira; Annemieke Cats; Nicoline Hoogerbrugge
Journal:  Int J Cancer       Date:  2011-10-23       Impact factor: 7.396

5.  Nonsyndromic cleft lip and palate is not associated with cancer or other birth defects.

Authors:  E F Steinwachs; C Amos; D Johnston; J Mulliken; S Stal; J T Hecht
Journal:  Am J Med Genet       Date:  2000-01-03

6.  Expression of E-cadherin during craniofacial development.

Authors:  C Lüning; A Rass; B Rozell; J Wroblewski; B Obrink
Journal:  J Craniofac Genet Dev Biol       Date:  1994 Oct-Dec

7.  Variants in members of the cadherin-catenin complex, CDH1 and CTNND1, cause blepharocheilodontic syndrome.

Authors:  Anneke Kievit; Federico Tessadori; Hannie Douben; Ingrid Jordens; Madelon Maurice; Jeannette Hoogeboom; Raoul Hennekam; Sheela Nampoothiri; Hülya Kayserili; Marco Castori; Margo Whiteford; Connie Motter; Catherine Melver; Michael Cunningham; Anne Hing; Nancy M Kokitsu-Nakata; Siulan Vendramini-Pittoli; Antonio Richieri-Costa; Annette F Baas; Corstiaan C Breugem; Karen Duran; Maarten Massink; Patrick W B Derksen; Wilfred F J van IJcken; Leontine van Unen; Fernando Santos-Simarro; Pablo Lapunzina; Vera L Gil-da Silva Lopes; Elaine Lustosa-Mendes; Max Krall; Anne Slavotinek; Victor Martinez-Glez; Jeroen Bakkers; Koen L I van Gassen; Annelies de Klein; Marie-José H van den Boogaard; Gijs van Haaften
Journal:  Eur J Hum Genet       Date:  2018-01-18       Impact factor: 4.246

8.  Identification of germline mutations in the cancer predisposing gene CDH1 in patients with orofacial clefts.

Authors:  Ingrid P Vogelaar; Joana Figueiredo; Iris A L M van Rooij; Joana Simões-Correia; Rachel S van der Post; Soraia Melo; Raquel Seruca; Carine E L Carels; Marjolijn J L Ligtenberg; Nicoline Hoogerbrugge
Journal:  Hum Mol Genet       Date:  2012-11-29       Impact factor: 6.150

9.  Blepharocheilodontic syndrome is a CDH1 pathway-related disorder due to mutations in CDH1 and CTNND1.

Authors:  Jamal Ghoumid; Morgane Stichelbout; Anne-Sophie Jourdain; Frederic Frenois; Sophie Lejeune-Dumoulin; Marie-Pierre Alex-Cordier; Marine Lebrun; Pierre Guerreschi; Veronique Duquennoy-Martinot; Matthieu Vinchon; Joel Ferri; Matthieu Jung; Serge Vicaire; Clemence Vanlerberghe; Fabienne Escande; Florence Petit; Sylvie Manouvrier-Hanu
Journal:  Genet Med       Date:  2017-03-16       Impact factor: 8.822

Review 10.  Passive smoking in the etiology of non-syndromic orofacial clefts: a systematic review and meta-analysis.

Authors:  Heba J Sabbagh; Mona Hassan Ahmed Hassan; Nicola P T Innes; Heba M Elkodary; Julian Little; Peter A Mossey
Journal:  PLoS One       Date:  2015-03-11       Impact factor: 3.240

View more
  6 in total

Review 1.  Hereditary diffuse gastric cancer: updated clinical practice guidelines.

Authors:  Vanessa R Blair; Maybelle McLeod; Fátima Carneiro; Daniel G Coit; Johanna L D'Addario; Jolanda M van Dieren; Kirsty L Harris; Nicoline Hoogerbrugge; Carla Oliveira; Rachel S van der Post; Julie Arnold; Patrick R Benusiglio; Tanya M Bisseling; Alex Boussioutas; Annemieke Cats; Amanda Charlton; Karen E Chelcun Schreiber; Jeremy L Davis; Massimiliano di Pietro; Rebecca C Fitzgerald; James M Ford; Kimberley Gamet; Irene Gullo; Richard H Hardwick; David G Huntsman; Pardeep Kaurah; Sonia S Kupfer; Andrew Latchford; Paul F Mansfield; Takeshi Nakajima; Susan Parry; Jeremy Rossaak; Haruhiko Sugimura; Magali Svrcek; Marc Tischkowitz; Toshikazu Ushijima; Hidetaka Yamada; Han-Kwang Yang; Adrian Claydon; Joana Figueiredo; Karyn Paringatai; Raquel Seruca; Nicola Bougen-Zhukov; Tom Brew; Simone Busija; Patricia Carneiro; Lynn DeGregorio; Helen Fisher; Erin Gardner; Tanis D Godwin; Katharine N Holm; Bostjan Humar; Caroline J Lintott; Elizabeth C Monroe; Mark D Muller; Enrique Norero; Yasmin Nouri; Joana Paredes; João M Sanches; Emily Schulpen; Ana S Ribeiro; Andrew Sporle; James Whitworth; Liying Zhang; Anthony E Reeve; Parry Guilford
Journal:  Lancet Oncol       Date:  2020-08       Impact factor: 41.316

2.  Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancer.

Authors:  M Aronson; C Swallow; A Govindarajan; K Semotiuk; Z Cohen; P Kaurah; L Velsher; I Ambus; K Buckley; C Forster-Gibson; W S Meschino; A Blumenthal; R H Kim; S Brar
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

3.  First report of a Mexican family with mutation in the CDH1 gene.

Authors:  Carmen Martínez Valenzuela; Edmundo Erbey Castelán-Maldonado; Octavio Carvajal-Zarrabal; Ana Laura Calderón-Garcidueñas
Journal:  Mol Genet Genomic Med       Date:  2020-09-04       Impact factor: 2.183

Review 4.  Endoscopic Surveillance in Patients with the Highest Risk of Gastric Cancer: Challenges and Solutions.

Authors:  Jessica M Long; Jessica Ebrahimzadeh; Peter P Stanich; Bryson W Katona
Journal:  Cancer Manag Res       Date:  2022-10-10       Impact factor: 3.602

5.  CDH1 Mutation Distribution and Type Suggests Genetic Differences between the Etiology of Orofacial Clefting and Gastric Cancer.

Authors:  Arthavan Selvanathan; Cheng Yee Nixon; Ying Zhu; Luigi Scietti; Federico Forneris; Lina M Moreno Uribe; Andrew C Lidral; Peter A Jezewski; John B Mulliken; Jeffrey C Murray; Michael F Buckley; Timothy C Cox; Tony Roscioli
Journal:  Genes (Basel)       Date:  2020-04-03       Impact factor: 4.096

Review 6.  Orofacial Cleft and Mandibular Prognathism-Human Genetics and Animal Models.

Authors:  Anna Jaruga; Jakub Ksiazkiewicz; Krystian Kuzniarz; Przemko Tylzanowski
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.